About the organization

About

Mexico Ibogaine is an independent information resource. Our mission is to provide clear, evidence-first guidance and practical editorial organization for people researching ibogaine, with emphasis on safety, legality, and reliable sourcing rather than clinical services.

We publish summaries, explainers, and structured guides about the topic to help readers identify questions to ask clinicians and facilities. For the public face of our editorial work, see the Services overview where we describe how content is organized for readers evaluating options and evidence.

Our editorial approach

Mexico Ibogaine organizes information with a clear editorial standard: identify source type, expose conflicts of interest, and prioritise primary evidence. We draw on clinical literature, public registries, and official guidance to explain where evidence exists and where it does not. For example, when referencing regulatory frameworks we consult government sources and established reference works to verify statements; this mirrors best practices used in academic communication such as those described on Wikipedia's scientific method overview.

Source-first
We prioritise peer-reviewed studies, registry data, and official guidance.
Transparent
We note limits, funding, and where data are missing.
Audience-first
Content is written for people researching ibogaine, not for promotion or sales.

What we cover

We provide topic-organized material intended to help readers form informed questions and compare publicly available information. Content areas include summaries of evidence types, safety considerations, regulatory context in Mexico, facility transparency practices, and aftercare planning. We do not operate clinics or provide individualized medical advice; instead our pages are structured to support decision-making and independent verification.

How information is organized

  1. Clear summaries that identify whether content is based on primary studies, registries, or experiential reports.
  2. Separate practical checklists and transparency scorecards for facility documentation and continuity of care.
  3. FAQ-style explainers for common procedural and legal questions facing researchers.

When we reference regulatory developments or policy, we link to authoritative public sources such as university-led reviews or government health sites; for example, official regulatory discussions often appear alongside academic syntheses similar to material hosted by NIH.

How information is sourced and vetted

Each page is created from a combination of primary literature, registries where available, official regulatory documents, and established secondary analyses. Claims that rely on clinical studies are linked to the original reports or systematic reviews when possible. We use conservative language where evidence is limited and explicitly note uncertainty.

For transparency practices and data standards we reference established frameworks and registries; readers can compare our sourcing approach to standard research transparency principles outlined by academic institutions such as Harvard University.

Independent by design

Mexico Ibogaine is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.

If you are exploring options or evaluating facilities, we recommend consulting licensed practitioners and official regulatory sites. For context on legislation and policy that may affect practice, some readers consult sources like the Texas advocacy site tracking state measures, for instance the Texas ibogaine bill tracker to understand how regional lawmaking can influence practice standards elsewhere.

Contact Services

Frequently asked practical questions

Below are short answers to common editorial-process questions about the resource.

How do you handle conflicts of interest?

We disclose funding and known affiliations on pages that rely on potentially conflicted sources. Where an author summarises industry-funded research, that funding line is recorded alongside the citation; this is consistent with university best practices for transparency described by many academic publishers such as those summarized on Wikipedia's open access entry.

Can I rely on this as medical advice?

No. Mexico Ibogaine is an independent information resource and not a medical provider. The content is not medical or legal advice; consult licensed clinicians for personal medical questions.

Where can I find regulatory updates?

We link to official government pages and academic summaries when available; readers often cross-check these primary sources directly with government health departments or academic centers that publish regulatory analyses.